This category centers on our premium somatotropic monotherapies, designed to isolate and map specific cellular mechanisms governing growth hormone secretion and regulation. By providing unblended compounds at maximum analytical purity, these research tools allow investigators to analyze targeted biological pathways without overlapping variables. Key selections include Ipamorelin, a highly selective ghrp-receptor agonist that stimulates pulsatile growth hormone release without elevating cortisol, prolactin, or aldosterone levels; CJC-1295 (available in both Mod GRF 1-29 and DAC modifications) to study extended plasma half-life and continuous pituitary stimulation; and MK-677 (Ibutamoren), a potent, orally active growth hormone secretagogue that mimics the action of endogenous ghrelin to investigate metabolic rate alterations, bone density pathways, and muscle mass retention.

To accommodate distinct clinical simulation demands or private-label manufacturing layouts, every sequence in this line is backed by completely adaptable packaging structures and custom box branding options. Rather than relying on fixed single-volume configurations, researchers can select precise dosing concentrations tailored directly to their brand or research requirements. Our available stock includes standard freeze-dried 10-vial kits (ranging from 2mg up to 10mg), ready-to-fill card tubes missing internal pen mechanisms, and uncompressed bulk raw powder weights for large-scale compounding frameworks.

Packaging Varieties:

• Ipamorelin Lyophilized Vials: 2mg, 5mg, and 10mg specifications (10 vials per box).

• CJC-1295 (Mod GRF 1-29 / Without DAC) Vials: 2mg and 5mg specifications (10 vials per box).

• CJC-1295 with DAC Vials: 2mg and 5mg specifications (10 vials per box).

• Sermorelin Lyophilized Vials: 2mg and 5mg specifications (10 vials per box).

• Alternative Forms: Oral capsules or liquid-stabilized formulations (specifically for MK-677 / Ibutamoren), or raw loose bulk freeze-dried powder material for wholesale production